Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bisphosphonates or RANK‐ligand‐inhibitors for Men With Prostate Cancer and Bone Metastases: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis. Accessed 12 September 2024.
Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis. Accessed September 12, 2024.
Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis
Bisphosphonates or RANK‐ligand‐inhibitors for Men With Prostate Cancer and Bone Metastases: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [cited 2024 September 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis
ID - 434640
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis
DB - Evidence Central
DP - Unbound Medicine
ER -